AI Insight
Researchers at the University of Manchester's Cancer Research UK Manchester Institute have identified a rare population of immune cells called activated dendritic cells that play a crucial role in coordinating the immune system's response against cancer. These specialized cells orchestrate the body's natural anti-cancer defenses, though they are difficult to locate and study. The findings have been accepted for publication in the peer-reviewed journal Immunity.
Why it matters
This discovery could lead to new cancer treatment approaches that harness or enhance the function of these dendritic cells to improve the body's natural ability to fight tumors. Understanding how these cells coordinate immune responses may help develop more effective immunotherapies for cancer patients.
Understand the Science
A little-known group of hard-to-find immune cells could help transform cancer treatment, scientists at the University of Manchester’s Cancer Research UK Manchester Institute have found. Their discovery, accepted for publication in the journal Immunity, centers on activated dendritic cells, a specialized population of immune cells that orchestrate the body’s attack on cancer. It is available on the SSRN preprint server.
Source: Scientists unmask immune cells that supercharge the fight against cancer